Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Fasting 9Prostatic Neoplasms 3Breast Neoplasms 3Intermittent Fasting 2Colorectal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Sarcoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Liposarcoma 1Infertility 1Histiocytoma, Malignant Fibrous 1Glioma 1Fibrosis 1Fasting in Malignant Solid Tumors 1Esophageal Neoplasms 1Dermatofibrosarcoma 1Childhood Cancer Survivors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Angptl4 protein, mouse × Clear all
NCT06536881 2025-08-17

GAMMER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
30 enrolled
Breast

Breast Neoplasms

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

NCT04330339 2022-07-21

Prolonged Nightly Fasting in Breast Cancer Survivors

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡